LOTUS, a possible endogenous inhibitor of axonal degeneration, as a new biomarker for multiple sclerosis.

Neurodegener Dis Manag

Molecular Medical Bioscience Laboratory, Department of Medical Life Science, Yokohama City University Graduate School of Medical Life Science, Yokohama, Japan.

Published: December 2015

Download full-text PDF

Source
http://dx.doi.org/10.2217/nmt.15.47DOI Listing

Publication Analysis

Top Keywords

lotus endogenous
4
endogenous inhibitor
4
inhibitor axonal
4
axonal degeneration
4
degeneration biomarker
4
biomarker multiple
4
multiple sclerosis
4
lotus
1
inhibitor
1
axonal
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!